Nurexone Biologic Inc (NRXBF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 1,466 | 1,822 | 1,700 | 1,484 | 1,285 |
| Operating Income | -1,466 | -1,822 | -1,700 | -1,484 | -1,285 |
| Interest Expense | 20 | 33 | 11 | 50 | 2 |
| Other Income | 21 | 9 | 33 | -12 | 37 |
| Pre-tax Income | -1,465 | -1,846 | -1,678 | -1,546 | -1,250 |
| Net Income Continuous | -1,465 | -1,846 | -1,678 | -1,546 | -1,250 |
| Net Income | $-1,465 | $-1,846 | $-1,678 | $-1,546 | $-1,250 |
| EPS Basic Total Ops | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| EPS Basic Continuous Ops | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| EPS Diluted Total Ops | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| EPS Diluted Continuous Ops | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| EPS Diluted Before Non-Recurring Items | -0.02 | -0.02 | -0.02 | -0.02 | -0.06 |
| EBITDA(a) | $-1,419 | $-1,780 | $-1,657 | $-1,445 | $-1,267 |